Alimentary Pharmacology & Therapeutics
Fecha de publicación: 10 April 2018
Autores: L. Kuhnhenn, B. Jiang, A. Kubesch, J. Vermehren, V. Knop, S. Susser, J. Dietz, G. Carra, F. Finkelmeier, G. Grammatikos, S. Zeuzem, C. Sarrazin, E. Hildt, K.‐H. Peiffer
Background: HBV DNA and quantitative (q)HBsAg levels as prognostic markers for HBV‐related disease are mostly validated in Asia and their significance in Western populations is uncertain.